ScholarIQanswers from OpenAlex & ORCID
Gabriel N. Hortobágyi
ResearcherPublications, citations & collaboration network
Gabriel N. Hortobágyi is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Gabriel N. Hortobágyi have?
ScholarIQindexed works
Gabriel N. Hortobágyi has 1,905 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Gabriel N. Hortobágyi have?
ScholarIQcitation count
Gabriel N. Hortobágyi has 141,209 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Gabriel N. Hortobágyi?
ScholarIQh-index
Gabriel N. Hortobágyi has an h-index of 187 in OpenAlex.
What is the i10-index of Gabriel N. Hortobágyi?
ScholarIQi10-index
Gabriel N. Hortobágyi has an i10-index of 937 in OpenAlex.
What is the ORCID of Gabriel N. Hortobágyi?
ScholarIQorcid
The ORCID for Gabriel N. Hortobágyi is on the source record.
What is the OpenAlex record for Gabriel N. Hortobágyi?
ScholarIQopenalex
The OpenAlex for Gabriel N. Hortobágyi is on the source record.
What are the most-cited papers on Gabriel N. Hortobágyi?
ScholarIQmost cited works
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess, Fabrice André, Attila Tordai, Jaime Mejia, W. Fraser Symmans, Ana M. González-Angulo, Bryan T. Hennessy, Marjorie Green, Massimo Cristofanilli, Gabriel N. Hortobágyi, Lajos Pusztai
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
Gabriel N. Hortobágyi, Salomon M. Stemmer, Howard A. Burris, Yoon Sim Yap, Gabe S. Sonke, Shani Paluch–Shimon, Mario Campone, Kimberly Blackwell, Fabrice André, Eric P. Winer, Wolfgang Janni, Sunil Verma, PierFranco Conte, Carlos L. Arteaga, David Cameron, Katarína Petráková, Lowell L. Hart, Cristian Villanueva, Arlene Chan, Erik Jakobsen, Arnd Nusch, Olga Burdaeva, Eva‐Maria Grischke, Emilio Alba, Erik Wist, Norbert Marschner, Anne Favret, Denise A. Yardley, Thomas Bachelot, Ling-Ming Tseng, Sibel Blau, Fengjuan Xuan, Farida Souami, Michelle C. Miller, Caroline Germa, Samit Hirawat, Joyce O’Shaughnessy
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
Benjamin D. Smith, Grace L. Smith, Arti Hurria, Gabriel N. Hortobágyi, Thomas A. Buchholz
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
W. Fraser Symmans, Florentia Peintinger, Christos Hatzis, Radhika Rajan, Henry M. Kuerer, Vicente Valero, Lina Assad, Anna W. Poniecka, Bryan T. Hennessy, Marjorie Green, Aman U. Buzdar, S. Eva Singletary, Gabriel N. Hortobágyi, Lajos Pusztai
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
Kathy S. Albain, William E. Barlow, Steven Shak, Gabriel N. Hortobágyi, Robert B. Livingston, I‐Tien Yeh, Peter M. Ravdin, Roberto Bugarini, Frederick L. Baehner, Nancy E. Davidson, George W. Sledge, Eric P. Winer, Clifford A. Hudis, James N. Ingle, Edith A. Perez, Kathleen I. Pritchard, Lois E. Shepherd, Julie R. Gralow, Carl Yoshizawa, D. Craig Allred, C. Kent Osborne, Daniel F. Hayes